Stockholm - Free Realtime Quote SEK

Senzime AB (publ) (SEZI.ST)

Compare
5.70 -0.10 (-1.72%)
As of 4:16 PM GMT+1. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. Philip Siberg Chief Executive Officer 4.6M -- 1973
Mr. Slavoljub Grujicic Chief Financial Officer -- -- 1970
Ms. Johanna Tulkki Chief Operating Officer -- -- 1970
Mr. Fredrik Norrby Chief Technology Officer -- -- 1976
Ms. Rianne Lundqvist Waninge Ph.D. Application Scientist -- -- --
Ms. Paula Treutiger Head of Communication & Investor Relations -- -- 1967
Mr. Anders Selin Executive Vice President of Sales -- -- 1962
Mr. Michael Noble Vice President Global Marketing -- -- 1988
Mr. Anders Jacobson Chief Innovation Officer -- -- 1967
Ms. Catrin Molund Executive Vice President of Business Development 163k -- 1970

Senzime AB (publ)

Ulls vAeg 41
Uppsala, 756 51
Sweden
46 18 51 56 40 https://www.senzime.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
52

Description

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. It offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance to measure the tissue's opposition to carrying an alternating electrical current. The company has a strategic connectivity and licensing agreement with Masimo to develop, manufacture, market, and distribute products that can connect to the Masimo Root patient monitoring system and related digital hub for data transmission to hospital electronic patient journals; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system. Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.

Corporate Governance

Senzime AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 13, 2025 at 7:30 AM UTC - February 17, 2025 at 7:30 AM UTC

Senzime AB (publ) Earnings Date

Recent Events

November 6, 2024 at 2:00 PM UTC

Q3 2024 Earnings Call

August 26, 2024 at 9:00 AM UTC

Q2 2024 Earnings Call

Related Tickers